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Abstract. Cyclooxygenase (COX), an enzyme involved in the conversion of 
arachidonic acid to prostaglandins, exists in two isoforms, which are COX-1 and 
COX-2. Despite the similarities of COX-1 and COX-2, the two isoforms show 
subtle differences in amino acid composition at the active sites. Since  COX-1 
has isoleucine, a bulkier amino acid  at position 523 than COX-2’s valine, it 
allows COX-2 to have a larger space in its active site.  Andrographolide reduces 
COX-2 expression induced by PAF and fMLP in HL60/neutrophils. 
Neoandrographolide inhibits COX-2 expression at the translational level. The 
purpose of this study is to examine the binding modes of andrographolide and 
neoandrographolide against COX-1 and COX-2 in terms of hydrogen bonds and 
docking energy, to understand their antiinflammatory property. The docking 
simulation indicates that both andrographolide and neoandrographolide are able 
to be located in the COX-2’s binding pocket but not in the COX-1’s. It confirms 
that COX-1’s binding pocket is smaller than COX-2’s. Based on this study, both 
andrographolide and neoandrographolide show selective inhibitory property to 
COX-2. Their selectivity are due to their specific interaction with Arg 513 in the 
binding pocket of COX-2, which is also shown by SC-558, a COX-2 selective 
inhibitor. 
Keywords: COX; andrographolide; neoandrographolide; docking simulation. 
1 Introduction 
Prostaglandin synthase catalyzes two separate reactions; the first being the 
cyclooxygenase function, which is the addition of molecular oxygen to 
arachidonic acid to form the unstable PGG2, and the second the further 
conversion of PGG2 to the more stable PGH2, which catalyzes the conversion of 
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hydroperoxide group to hydroxyl group by hydroperoxide function. Hence this 
COX enzyme performs a critical initial reaction in the arachidonic metabolic 
cascade leading to the formation of prostaglandins, thromboxan and 
prostacyclin [1].  
Two known isoforms of COX, named COX-1 and COX-2, show distinct 
expression patterns and distinct biological activities. COX-1 is constitutively 
expressed protein formed in many different cells and responsible for the 
production of prostaglandins. COX-2 is rapidly up-regulated at inflammatory 
sites and appeared responsible for the formation of proinflammatory 
prostanoids. COX-1, meanwhile, appeared to shoulder the responsibility for the 
production of physiologically relevant prostanoids such as those in the stomach 
and platelets [2,3,4]. In inflammatory processes COX-2 is overexpressed [5]. 
The two isoforms are 63% identical and 77% similar at amino acids level. 
Based on the sequence alignment of human COX-1 and COX-2, the major 
differences are in the N-terminal and C-terminal regions. Structural differences 
that are responsible for selectivity are believed to be found in the 
cyclooxygenase active site. One difference is observed at the cyclooxygenase 
active site, where the isoleucine at position 523 in COX-1 is a valine in COX-2 
[1]. Other researchers reported that despite the similarities of COX-1 and COX-
2, the two isoforms show subtle differences in amino acid composition at the 
active sites, i.e. the bulky isoleucine at position 523, while COX-2 has valine, 
hence resulting a larger space in the active site of COX-2. This difference is 
believed to induce the selectivity of some inhibitors [2].  
The leaves of Andrographis paniculata (Burm.F) Nees had been empirically 
used to treat inflammations in Indonesia, especially by the Javanese. 
Andrographolide and neoandrographolide are diterpenoid compounds isolated 
from  Andrographis paniculata (Burm.F) Nees [6]. The two compounds are 
classified as lactone bicyclic diterpenoids, which have been reported to have 
antiinflammatory activity. Andrographolide reduces COX-2 expression induced 
by PAF and fMLP in HL60/neutrophils, as reported by Maria A. Hidalgo et al 
[7]. Neoandrographolide inhibits COX-2 expression at the translational level, as 
reported by J. Liu and colleagues from Shanghai University [8]. In this paper 
the binding modes of andrographolide and neoandrographolide against COX 
enzymes in terms of hydrogen bonds and docking energy were studied to 
understand their antiinflammatory activity. 
2 Results  
Stochastic conformational search using molecular mechanics method of MOE-
2007.09.02 software was performed to find the individual energy minimum 
state. The molecular mechanics considers the atomic composition of a molecule 
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to be a collection of masses interacting with each other via harmonic forces. As 
a result of this simplification, molecular mechanics is a relatively fast 
computational method practicable for small molecules as well as for larger 
molecules and even oligomolecular systems. This search resulted eleven 
conformers for andrographolide and seven conformers for neoandrographolide. 
Both molecules are flexible due to their many single bonds. The flexibility of 
andrographolide and neoandrographolide leads to their tendency to interact with 
their targets more easily. 
The molecular surfaces of andrographolide and neoandrographolide showed that 
both molecules are likely to form hydrogen bonds considering their carbonyl, 
lactone and hydroxyl (Figure 1). 
 
(a)    (b) 
Figure 1 Electrostatic map of (a) andrographolide (b) neoandrographolide. The 
blue color indicated electron-donating area. 
Table 1 Similarity study. 
Aligned 
compounds 
Similarity terms  
(Default setting) 
Similarity terms  
(aromaticity, acid/base, 
hydrophobe area, polar hydrogens, 
log P, molar refractivity, partial 
charge, volume) 
F S dU F S dU 
Andographolide 
and flurbiprofen 
221.1373 286.4565 0.0000 126.2464 194.7328 2.7613 
Andrographolide 
and SC-558 
157.5603 214.5916 0.0000 110.4931 166.8766 0.0000 
 
F =  similarity 
S =  objective function 
dU =  the difference between lowest potential energy and the  
    global minimum 
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Similarity study was performed by using flexible alignment tool which aligned 
two or more molecules with several similarity terms and weighing parameters. 
We have chosen  aromaticity, acid/base, hydrophobe area, polar hydrogens, 
lipophilicity (log P value), molar refractivity, partial charge, and volume as the 
similarity parameters, and all parameters were weighed 1 (Table 1 and Figure 
2). 
   
(a) (b)            
Figure 2 Flexible alignment of andrographolide (green) and flurbiprofen (blue) 
andrographolide (green) and SC-558 (red). 
 
Figure 3 Alignment of COX-2 (code 3PGH) and COX-1 (code 1EQH) crystal 
structures represent the same site in which their non-selective inhibitor, 
flurbiprofen was co-crystallized. 
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Andrographolide shows similarity to SC-558 than to flurbiprofen (dU value of 
andrographolide and SC-558 at different settings is 0.0000). The smaller the 
value of F and S indicates similarity of the compounds aligned. 
 
 
                                      (a)                                                                   (b) 
Figure 4 (a). Flurbiprofen’s interaction in the binding site of COX1. The arrow 
showed Ile 523, specific amino acid in COX1 binding site. (b). Flurbiprofen in 
the binding site of COX1. 
Analysis of binding sites in COX-1 and COX-2 enzymes were performed by 
aligning crystal structures of the two enzymes (code 1EQH and 3PGH), in 
which flurbiprofen was co-crystallized, and examining the site where it was 
bound. Amino acid residues involved in the binding site of COX1 were His 90, 
Arg 120, Val 349, Leu 352, Ser 353, Tyr 355, Trp 387,  Phe 518, Met 522, Ile 
523, Gly 526, Ala 527, Ser 530,  Leu 534,  while in COX2 were His 90, Leu 
117, Val 349, Leu 352,  Ser 353, Tyr 355, Trp 387, Ala 516, Phe 518, Met 522, 
Val 523, Gly 526, Ala 527, Ser 530, Leu 534. In both enzymes, flurbiprofen lies 
exactly in the same site (Figure 3). The ligand formed two hydrogen bonds with 
Arg 120 and Tyr 355 (Figure 4). Further analyze of COX-2 interaction with its 
selective inhibitor SC-558 (code 1CX2) were performed.  SC-558 shows 
hydrogen bond interactions with Arg 513 and Gln 192 (Figure 5). The position 
of Arg 513 is at the lower side of the pocket, which means that the pocket of 
COX-2 is larger in size than COX-1’s. The interaction of SC-558 with Arg 513 
might be important because it makes this ligand selective to inhibit COX-2 
activity. 
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                            (a)                                                       (b) 
Figure 5  (a) SC-558, a selective inhibitor of COX2, interacted with Arg 513 
and Gln 192 in the binding site of COX2. The arrow showed Val 523, specific 
amino acid in COX2 binding site which makes COX2’s binding pocket larger in 
size than COX1’s. (b) SC-558 in the binding site of COX2. 
 
 
Figure 6 Docking simulation of andrographolide into the binding site of COX2. 
Hydrogen bonds are showed by black arrows. 
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Figure 7 Docking simulation of neoandrographolide into the binding site of 
COX2. Hydrogen bonds are showed by black arrows. 
To identify and visualize the antiinflammatory activity of andrographolide and 
neoandrographolide, docking calculations were performed using MOE-
2007.09.02 into the 3D structures of the catalytic site of COX-1 (PDB code: 
EQH) and COX-2 (PDB code: 1CX2) enzymes. Andrographolide and 
neoandrographolide cannot be docked into the COX-1 binding pocket, probably 
due to the size of the pocket. This indicates that COX-1 binding pocket is 
smaller than COX-2. We have tried to force the compounds to be docked into 
the COX-1 binding pocket (by using AutoDock v.3.0.5 software), but it resulted 
in large value of inhibition constant, Ki, and positive value in docking energy, 
which meant that the interactions were not favourable (data was not showed). 
However, andrographolide shows interaction with the COX-2 binding pocket 
(Figure 6) through forming hydrogen bonds between oxygen atom in 
andrographolide’s lactone ring (HB acceptor) and hydrogen atom in the Arg 
513’s amine and His 90’s pyridine (HB donors), while neoandrographolide 
forms  hydrogen bonds with Arg 513 (Figure 7). 
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3 Discussion 
Andrographolide and neoandrographolide, diterpenoid compounds  from  
Andrographis paniculata (Burm.F) Nees have been reported to have 
antiinflammatory activity in vitro. This study has confirmed that this activity 
might be caused by their interactions with the binding pocket of COX-2 
enzymes. Both molecules, which has potential moieties to form hydrogen 
bonds,  e.g.  oxygen and hydrogen atoms in the hydroxyl groups and oxygen 
atom in the lactone ring and carbonyl groups, are shown to form hydrogen 
bonds with Arg 513, His 90 and other amino acids in the pocket.  
We have analyzed the interaction of COX-2 selective inhibitor, SC-558, in the 
binding pocket of COX-2. The compound, which has smaller size compared to 
andrographolide and neoandrographolide, shows only one specific interaction in 
the pocket by forming hydrogen bond with Arg 513. We hypothesized that if 
any compounds made the same interactions, by means : building hydrogen 
bonds with Arg 513 (which is located at the lower site of the pocket), then the 
compounds would be potential as selective inhibitors of COX2. In this study, it 
was confirmed by employing molecular modeling approach using docking 
simulation of the two compounds into both COX-1 and COX-2 binding pockets.  
Andrographolide and neoandrographolide are more favourable to interact with 
COX-2’s binding pocket than SC-558 (Figure 6 and 7), which is proven by the 
formation of hydrogen bonds and the value of docking energy. Hydrogen bonds 
are formed between oxygen atom in andrographolide’s lactone ring (HB 
acceptor) and hydrogen atom in the Arg 513’s amine and His 90’s pyridine (HB 
donors), while the value of docking energy is -10.64 kcal/mol.  
Neoandrographolide’s hydroxyl which is attached at its lactone ring forms  
hydrogen bonds with Arg 513’s amine, while its docking energy value is -7.77 
kcal/mol. It should be noted that SC-558 only forms one hydrogen bond with 
Arg 513.  
This study might be useful to visualize and understand the interactions of 
andrographolide and neoandrographolide to cyclooxygenase enzymes at 
molecular level. 
4 Conclusions 
The docking simulation indicates that both andrographolide and 
neoandrographolide can not interact with COX-1’s binding pocket, probably 
due to the size of the pocket. Andrographolide and neoandrographolide show 
interactions with COX-2’s binding pocket by forming hydrogen bonds to Arg 
513, His 90 and other amino acids in the pocket. Their selectivity is due to their 
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specific interactions with Arg 513 in the binding pocket of COX-2, which is 
also shown by SC-558, a COX-2 selective inhibitor. 
5 Experimental 
5.1 Data Preparation 
The  x-ray crystallographic 3D structures of COX-1 (PDB code: 1EQH ) and 
COX-2  (PDB codes: 1CX2 and 3PGH) were downloaded from online Protein 
Data Bank  (http://www.rcsb.org/pdb/). 2D and 3D structures of 
andrographolide and neoandrographolide were built using Molecular Operating 
Environment (MOE-2007.09.02). 
Docking andrographolide and neoandrographolide to COX-1 and COX-2 
enzymes were carried out using MOE-2007.09. 02. 
5.2 Molecular Modeling 
MOE-2007.09.02 was applied to build the ligands. Energy minimization to each 
molecule was carried out by using molecular mechanics forcefield MMFF94x. 
Stochastic conformational search with molecular mechanics method was 
performed to find the lowest energy conformers. Molecular surfaces of 
andrographolide and neoandrographolide, by means their electrostatic maps, 
were  also computed. Hydrogens were added to all COX enzymes PDB crystal 
structures followed by calculating the partial charges by using Amber 99. Site 
finder tool was performed to each crystal structure molecule to predict the most 
likely sites for the ligand-enzyme interactions. MOE sequence editor was used 
to analyze the amino acid sequences in the enzyme. Flexible alignment was 
applied to analyze the similarity of andrographolide and flurbiprofen and SC-
558. 
5.3 Analysis of Binding Site Residues 
X-ray crystallographic 3D structures of COX-1 (PDB code: 1EQH)  and COX-2 
(PDB code : 3PGH), both complexed with  the non-selective inhibitor 
flurbiprofen, were studied to obtain information about their differences,  which 
in this case refered to the amino acid residues in the binding sites. A 
comparative study using 1CX2, an x-ray crystallographic structure of COX2 
complexed with a selective inhibitor SC-558, was performed to understand the 
ligand’s selective inhibition property to COX2. 
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5.4 Ligand-Protein Docking 
The prediction of interaction of andrographolide and neoandrographolide to 
COX-2  is the main challenge to understand their antiinflammatory property. 
The goal is to take the 3D coordinates of the enzyme and its complexed ligand 
(SC-558) which has been known as a selective inhibitor to COX-2, and to 
simulate the docking of our compounds into the site in which SC-558 was co-
crystallized. The interactions between SC-558 and COX-2 binding site was 
analyzed and compared with andrographolide and neoandrographolide’s. 
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